iBio

$1.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-4.86%) Today
+$0.05 (+2.84%) As of 10:36 AM UTC after-hours

Why Robinhood?

You can buy or sell iBio and other stocks, options, and ETFs commission-free!

About IBIO

iBio, Inc., also called iBio, is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the iBio, Inc. and iBio CDMO business segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX. The listed name for IBIO is iBio, Inc.

CEO
Thomas F. Isett
Employees
4
Headquarters
New York, New York
Founded
1993
Market Cap
415.11M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
15.28M
High Today
$1.89
Low Today
$1.77
Open Price
$1.81
Volume
6.12M
52 Week High
$7.45
52 Week Low
$0.50

IBIO Earnings

-$0.04
-$0.03
-$0.01
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.04 per share
Actual
-$0.04 per share
Replay Earnings Call

You May Also Like

UVXY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure